monotherapy

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

monotherapy

Jul 19, 2024, 22:56 | Insight

Stunning interim clinical trial data from Revolution Medicines

Grainne O'Kane, Medical Oncologist at Princess Margaret Cancer Centre, shared a post by Kenneth Olive,…

Jul 10, 2024, 06:36 | Insight

Paolo Tarantino: Intersecting data with the MAT2A inhibitor IDE397 in MTAPdel lung and urothelial cancer

Paolo Tarantino shared a post by Bio Stocks on X, adding: . "Intersecting data with…

May 6, 2024, 19:10 | Blog

Erman Akkus: ASCO Ed book on mNSCLC without oncogenic alterations

Erman Akkus, medical oncologist at Ankara Medical University, shared on Twitter/X: "Metastatic NSCLC without oncogenic…

May 2, 2024, 15:25 | Blog

Tanja Obradovic: Interesting updates will be coming on ASCO 2024

Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: "ASCO 2024 is almost…

Aug 11, 2023, 17:44 | Insight

Vivek Subbiah: Pleased to share our back-to-back papers unveiling promising results of Lurbinectedin

Hot off the press Pleased to share our back-to-back papers unveiling promising results of Lurbinectedin.…

Jul 11, 2023, 15:33 | Drugs

First patient dosed in combination trial of OBT076 and CPI Balstilimab - Oxford BioTherapeutics

We are pleased to announce that the first patient has been dosed in a Phase…

Jul 10, 2023, 03:08 | Opinion

Study showed better OS & quality of life with Atezo - Rami Manochakian, MD

Hot off the press @TheLancet IPSOS phase 3 trial of 1st line Atezolizumab monotherapy vs…

Jun 19, 2023, 18:11 | Drugs

Antibody-drug conjugates (ADCs) have emerged as one of the fastest-growing oncology therapeutics - Antonio Passaro

I am delighted to share the our recent publication in JCO titled "Antibody-Drug Conjugates in…

All: 8 Posts: 1 - 100